Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up

Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up

AbstractBackground This is the first study to examine the clinical utility of measuring plasma secretoneurin (SN) levels in patients with heart failure with reduced ejection fraction (HFrEF), as a predictor of unplanned hospitalization, and all-cause mortality independently, and as a composite endpo...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Łukasz Wołowiec, Daniel Rogowicz, Jacek Budzyński, Joanna Banach, Anna Wołowiec, Mariusz Kozakiewicz, Maciej Bieliński, Albert Jaśniak, Joanna Osiak, Grzegorz Grześk
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: Taylor & Francis Group 2024-12-01
Ráidu:Annals of Medicine
Fáttát:
Secretoneurin
heart failure
HFrEF
biomarker
cardiovascular system
Liŋkkat:https://www.tandfonline.com/doi/10.1080/07853890.2024.2305309

Interneahtta

https://www.tandfonline.com/doi/10.1080/07853890.2024.2305309

Geahča maid